COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response

The COVID-19 pandemic caused by SARS-CoV-2 sparked intensive research into the development of effective vaccines, 50 of which have been approved thus far, including the novel mRNA-based vaccines developed by Pfizer and Moderna. Although limiting the severity of the disease, the mRNA-based vaccines p...

Descripción completa

Detalles Bibliográficos
Autores principales: Affonso de Oliveira, Jessica Fernanda, Zhao, Zhongchao, Xiang, Yi, Shin, Matthew D., Villaseñor, Kathleen Elizabeth, Deng, Xinyi, Shukla, Sourabh, Chen, Shaochen, Steinmetz, Nicole F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157238/
https://www.ncbi.nlm.nih.gov/pubmed/37152732
http://dx.doi.org/10.3389/fmicb.2023.1117494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157238/
https://www.ncbi.nlm.nih.gov/pubmed/37152732
http://dx.doi.org/10.3389/fmicb.2023.1117494

Ejemplares similares